Vivos Therapeutics, Inc. has partnered with CE Zoom for the distribution of CE Certificates.
Please register for each course being offered, for which you wish to receive a CE Certificate of Attendance.
Registration is FREE.
Login using your CE Zoom account.
Not a CE Zoom member?
Overview
Over the past one hundred years, dentists have observed a rapid and steady increase in the number of patients who present with crooked and crowded teeth, bruxism and required orthodontic intervention. In many cases, these signs can indicate a much more serious problem. Underdeveloped upper and lower jaws may indicate an underlying and potentially serious medical condition—sleep disordered breathing including mild-to-moderate obstructive sleep apnea. Obstructive sleep apnea, a condition which affects millions of people of all ages, is often the result of craniofacial developmental deficiencies—putting dentistry on the front line of treating this condition.
Breathe New Life is an innovative course designed to help dentists and their staff begin to connect the dots and to ultimately recognize their essential role.
This course is designed to provide clinical insights and information to help dentists begin the process of integrating sleep therapies into their practice. During this seven and a half hour course, you and your staff will achieve a basic knowledge of the clinical realities facing individuals who suffer from craniofacial developmental deficiencies. Lectures will introduce the key differences between treating the symptoms and addressing the underlying cause. You will gain insight into the anatomy of sleep disordered breathing including obstructive sleep apnea and learn how this problem can and should be addressed in your office. You will hear from leading experts in sleep and breathing health as well as clinicians who are successfully treating patients using a novel protocol and advanced therapeutics.
You will also hear from one of the world’s foremost experts in medical billing in the dental office to learn how medical billing can provide an additional wallet to help patients in their journey to health and wellness. Finally, this course will provide practical tips to help you see a clear path to integrating sleep medicine into your practice.
Vivos is registered, with the FDA, as a Specification Developer:
Vivos mRNA(Mandibular Repositioning Nightime Appliance): FDA CLEARED as a Class 2 appliance; cleared for the treatment of adult patients diagnosed with mild to moderate sleep apnea, snoring and sleep disordered breathing.
Vivos DNA(Daytime Nightime Appliance): FDA REGISTERED as a Class 1 appliance for palatal expansion
Vivos Guide Series(VStarter, VGrow, VWay): FDA REGISTERED as Class 1 appliances for teeth straightening
"This presentation is intended for educational purposes only. Statements of facts and opinions expressed are those of the educator/doctor individually, and unless expressly stated to the contrary, are not the opinion of the course sponsor, Vivos Therapeutics, Inc.”
Vivos Therapeutics, Inc. is approved by AGD / PACE to issue CE credits to any individuals that attend our CE programs. Whether or not the credits will be accepted by the licensing / regulatory bodies across the World is up to those regulatory bodies.
Date / Time
Fri, Mar 12, 2021
Location
Online
Tuition
Promo Code
Friday Mar 12th 2021
Time
Title
Credits
08:30 AM - 09:45 AM MT
SUMMIT - Craniofacial Epigenetic and Pneumodedics
1.50
Overview:
Dr. Dave Singh DMD PhD DDSc
Prof. Dave Singh is a US citizen who was born, educated and trained in England, UK. He holds three doctorates, including Doctor of Dental Medicine; a Ph.D. in Craniofacial Development, and a D.D.Sc. in Orthodontics. On the basis of being an “outstanding professor” (supported by University of Michigan, Harvard University and University of Hawaii), he was invited to relocate to the Center for Craniofacial Disorders, USA where he led a NIH-funded program of craniofacial research. Currently, he is a Board Member of the American Sleep and Breathing Association, Member of the World Sleep Federation, an Academic Fellow of the World Federation of Orthodontists, and Fellow of the International Association for Orthodontics, where he was awarded prizes in 2005, 2013 and 2014. Dr Singh holds several patents in the US, Canada and Europe as well as internationally. He has published over 200 articles and books in the peer-reviewed medical, dental and orthodontic literature, and has lectured in Australia, Asia, Europe, Africa and North America.
OVERVIEW:
Defining Craniofacial Epigenetics
Biomimetic Oral Appliance Therapy
Long Term Effects of CPAP and Mandibular Advancement Devices
Vivos is registered, with the FDA, as a Specification Developer:
Vivos mRNA(Mandibular Repositioning Nightime Appliance): FDA CLEARED as a Class 2 appliance; cleared for the treatment of adult patients diagnosed with mild to moderate sleep apnea, snoring and sleep disordered breathing.
Vivos DNA(Daytime Nightime Appliance): FDA REGISTERED as a Class 1 appliance for palatal expansion
Vivos Guide Series(VStarter, VGrow, VWay): FDA REGISTERED as Class 1 appliances for teeth straightening
The presentation is intended for educational purposes only and Vivos Therapeutics, Inc. is not responsible for the doctor to doctor discussions during the sessions. Statements of facts and opinions expressed are those of the educator individually and unless expressly stated to the contrary, are not the opinion of Vivos Therapeutics, Inc.
Vivos Therapeutics, Inc. is approved by AGD / PACE to issue CE credits to any individuals that attend our CE programs. Whether or not the credits will be accepted by the licensing / regulatory bodies across the World is up to those regulatory bodies.
Presenter: Dr. Dave Singh DMD PhD DDSc
Credits: 1.50
Course Contact: Cayon@vivoslife.com
Course Categories: Epidemiology,Oral / Dental Health Care & Conditions (Hypersensitivity, Trauma, Halitosis, Xerostomia, Orofacial Pain, Oral Complications to Medicine Use, etc)
Provider Approval: Nationally Recognized (AGD-PACE) Academy of General Dentistry Program approval for Continuing Education
Educational Type: Live
Educational Method: Lecture
Prerequisites:
NONE
Sponsor(s): Vivos Therapeutics, Inc.
Conflict of Interest Disclosure: Affiliated and/or Associated with
Presenter is the Chief Medical Officer at Vivos Therapeutics, Inc.
SUMMIT - Craniofacial Deficiencies, A biological Perspective
1.00
Overview:
Dr. Ben Miraglia, DDS -
SUNY Buffalo School of Dental Medicine - Presidents Council –Northern Westchester Hospital - Board of Directors – American Academy of Physiological Medicine & Dentistry - Vivos Therapeutics, Inc. Clinical Advisor - Align Technology Faculty Member - 26 Years Family Care Practice in Mount Kisco, NY - 16 Years Early Growth and Development Experience - Dentistry Today – Leaders in CE since 2015. His early intervention treatment includes, but is not limited to, appliance therapy. In the more than 3,000 cases Dr. Miraglia has treated, he has used oral appliances from Vivos®, Myobrace®, Ortho-Tain®, Rocky Mountain Orthodontics®, lnvisalign®, etc.
Overview:
Pediatric Sleep Disordered Breathing
Growth and development
Space management and maintenance
Palatal Expansion
Myofuntional Therapy
Nasal Clearing
Vivos is registered, with the FDA, as a Specification Developer:
Vivos mRNA(Mandibular Repositioning Nightime Appliance): FDA CLEARED as a Class 2 appliance; cleared for the treatment of adult patients diagnosed with mild to moderate sleep apnea, snoring and sleep disordered breathing.
Vivos DNA(Daytime Nightime Appliance): FDA REGISTERED as a Class 1 appliance for palatal expansion
Vivos Guide Series(VStarter, VGrow, VWay): FDA REGISTERED as Class 1 appliances for teeth straightening
The presentation is intended for educational purposes only and Vivos Therapeutics, Inc. is not responsible for the doctor to doctor discussions during the sessions. Statements of facts and opinions expressed are those of the educator individually and unless expressly stated to the contrary, are not the opinion of Vivos Therapeutics, Inc.
Vivos Therapeutics, Inc. is approved by AGD / PACE to issue CE credits to any individuals that attend our CE programs. Whether or not the credits will be accepted by the licensing / regulatory bodies across the World is up to those regulatory bodies.
Presenter: Ben Miraglia, DDS
Credits: 1.00
Course Contact: Cayon@vivoslife.com
Course Categories: Orthodontics,Care and Treatment of Children / Pediatric Care
Provider Approval: Nationally Recognized (AGD-PACE) Academy of General Dentistry Program approval for Continuing Education
Educational Type: Live
Educational Method: Lecture
Prerequisites:
NONE
Sponsor(s): Vivos Therapeutics, Inc.
Conflict of Interest Disclosure: Affiliated and/or Associated with
Presenter is Affiliated with Vivos Therapeutics, Inc.
SUMMIT - Treating Sleep Disordered Breathing & OSA using Oral Appliance Therapy
1.50
Overview:
OVERVIEW:
What is craniofacial sleep medicine?
Explore the root cause of sleep-disordered breathing including obstructive sleep apnea, a condition that affects hundreds of your patients. Receive an introduction to the most recent discoveries that are guiding the evolution of this important field in modern dentistry.
Learn how advanced treatment modalities in craniofacial sleep medicine in dentistry, including biomimetics and Pneumopedics®, are delivering hope for lasting resolution for patients suffering from sleep and breathing disorders and related comorbidities.
Vivos is registered, with the FDA, as a Specification Developer
Vivos System Appliances:
Vivos mRNA(Mandibular Repositioning Nightime Appliance): FDA CLEARED as a Class 2 appliance; cleared for the treatment of adult patients diagnosed with mild to moderate sleep apnea, snoring and sleep disordered breathing.
Vivos DNA(Daytime Nightime Appliance): FDA REGISTERED as a Class 1 appliance for palatal expansion
Vivos Guide Series(VStarter, VGrow, VWay): FDA REGISTERED as Class 1 appliances for teeth straightening
The presentation is intended for educational purposes only and Vivos Therapeutics, Inc. is not responsible for the doctor to doctor discussions during the sessions. Statements of facts and opinions expressed are those of the educator individually and unless expressly stated to the contrary, are not the opinion of Vivos Therapeutics, Inc.
Vivos Therapeutics, Inc. is approved by AGD / PACE to issue CE credits to any individuals that attend our CE programs. Whether or not the credits will be accepted by the licensing / regulatory bodies across the World is up to those regulatory bodies.
Presenter: Dr. Tammarie Heit
Credits: 1.50
Course Contact: cayon@vivoslife.com
Course Categories: Epidemiology,Oral / Dental Health Care & Conditions (Hypersensitivity, Trauma, Halitosis, Xerostomia, Orofacial Pain, Oral Complications to Medicine Use, etc)
Provider Approval: Nationally Recognized (AGD-PACE) Academy of General Dentistry Program approval for Continuing Education
Educational Type: Live
Educational Method: Lecture
Prerequisites:
NONE
Sponsor(s): Vivos Therapeutics, Inc.
Conflict of Interest Disclosure: Affiliated and/or Associated with
Presenter is Affiliated with Vivos Therapeutics, Inc.
SUMMIT - Medical Billing in a Healthy Airway Practice
1.00
Overview:
Overview:
"You will have to decide how you are going to deal with medical insurance. You cannot ignore it."
Dr. Chris Farrugia
Vivos is registered, with the FDA, as a Specification Developer
Vivos System Appliances:
Vivos mRNA(Mandibular Repositioning Nightime Appliance): FDA CLEARED as a Class 2 appliance; cleared for the treatment of adult patients diagnosed with mild to moderate sleep apnea, snoring and sleep disordered breathing.
Vivos DNA(Daytime Nightime Appliance): FDA REGISTERED as a Class 1 appliance for palatal expansion
Vivos Guide Series(VStarter, VGrow, VWay): FDA REGISTERED as Class 1 appliances for teeth straightening
The presentation is intended for educational purposes only and Vivos Therapeutics, Inc. is not responsible for the doctor to doctor discussions during the sessions. Statements of facts and opinions expressed are those of the educator individually and unless expressly stated to the contrary, are not the opinion of Vivos Therapeutics, Inc.
Vivos Therapeutics, Inc. is approved by AGD / PACE to issue CE credits to any individuals that attend our CE programs. Whether or not the credits will be accepted by the licensing / regulatory bodies across the World is up to those regulatory bodies.
Presenter: Dr. Chris Farrugia
Credits: 1.00
Course Contact: Cayon@vivoslife.com
Course Categories: Epidemiology,Oral / Dental Health Care & Conditions (Hypersensitivity, Trauma, Halitosis, Xerostomia, Orofacial Pain, Oral Complications to Medicine Use, etc)
Provider Approval: Nationally Recognized (AGD-PACE) Academy of General Dentistry Program approval for Continuing Education
Educational Type: Live
Educational Method: Lecture
Prerequisites:
NONE
Sponsor(s): Vivos Therapeutics, Inc.
Conflict of Interest Disclosure: Affiliated and/or Associated with
Presenter is Affiliated with Vivos Therapeutics, Inc.
Patrick McKeown, author of The Oxygen Advantage and new The Breathing Cure.
Every day as dentist, you’re seeing patients who suffer from breathing issues including sleep apnea - and dentistry plays a vital role in identifying and even treating this serious health condition.
Vivos is registered, with the FDA, as a Specification Developer
Vivos mRNA(Mandibular Repositioning Nightime Appliance): FDA CLEARED as a Class 2 appliance; cleared for the treatment of adult patients diagnosed with mild to moderate sleep apnea, snoring and sleep disordered breathing.
Vivos DNA(Daytime Nightime Appliance): FDA REGISTERED as a Class 1 appliance for palatal expansion
Vivos Guide Series(VStarter, VGrow, VWay): FDA REGISTERED as Class 1 appliances for teeth straightening
The presentation is intended for educational purposes only and Vivos Therapeutics, Inc. is not responsible for the doctor to doctor discussions during the sessions. Statements of facts and opinions expressed are those of the educator individually and unless expressly stated to the contrary, are not the opinion of Vivos Therapeutics, Inc.
Vivos Therapeutics, Inc. is approved by AGD / PACE to issue CE credits to any individuals that attend our CE programs. Whether or not the credits will be accepted by the licensing / regulatory bodies across the World is up to those regulatory bodies.
Presenter: Patrick McKeown, M.A. (TCD)
Credits: 2.50
Course Contact: Cayon@vivoslife.com
Course Categories: Epidemiology,Oral / Dental Health Care & Conditions (Hypersensitivity, Trauma, Halitosis, Xerostomia, Orofacial Pain, Oral Complications to Medicine Use, etc)
Provider Approval: Nationally Recognized (AGD-PACE) Academy of General Dentistry Program approval for Continuing Education